JP2011512405A5 - - Google Patents

Download PDF

Info

Publication number
JP2011512405A5
JP2011512405A5 JP2010547565A JP2010547565A JP2011512405A5 JP 2011512405 A5 JP2011512405 A5 JP 2011512405A5 JP 2010547565 A JP2010547565 A JP 2010547565A JP 2010547565 A JP2010547565 A JP 2010547565A JP 2011512405 A5 JP2011512405 A5 JP 2011512405A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
acid addition
following
present
various novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010547565A
Other languages
English (en)
Japanese (ja)
Other versions
JP5543377B2 (ja
JP2011512405A (ja
Filing date
Publication date
Priority claimed from KR1020080015336A external-priority patent/KR101188333B1/ko
Application filed filed Critical
Publication of JP2011512405A publication Critical patent/JP2011512405A/ja
Publication of JP2011512405A5 publication Critical patent/JP2011512405A5/ja
Application granted granted Critical
Publication of JP5543377B2 publication Critical patent/JP5543377B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010547565A 2008-02-20 2009-02-20 経皮ドラッグデリバリーシステムとして効果的な安定性を有するトルテロジン酸付加塩 Expired - Fee Related JP5543377B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2008-0015336 2008-02-20
KR1020080015336A KR101188333B1 (ko) 2008-02-20 2008-02-20 안정성이 우수하고 경피제로 유용한 톨테로딘 결정성산부가염
PCT/KR2009/000814 WO2009104920A1 (en) 2008-02-20 2009-02-20 Acid salt of tolterodine having effective stability for transdermal drug delivery system

Publications (3)

Publication Number Publication Date
JP2011512405A JP2011512405A (ja) 2011-04-21
JP2011512405A5 true JP2011512405A5 (enExample) 2012-04-05
JP5543377B2 JP5543377B2 (ja) 2014-07-09

Family

ID=40985718

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010547565A Expired - Fee Related JP5543377B2 (ja) 2008-02-20 2009-02-20 経皮ドラッグデリバリーシステムとして効果的な安定性を有するトルテロジン酸付加塩

Country Status (7)

Country Link
US (1) US8367726B2 (enExample)
EP (1) EP2247569B1 (enExample)
JP (1) JP5543377B2 (enExample)
KR (1) KR101188333B1 (enExample)
CN (1) CN101980999B (enExample)
ES (1) ES2516704T3 (enExample)
WO (1) WO2009104920A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012051875A (ja) * 2010-08-03 2012-03-15 Hisamitsu Pharmaceut Co Inc 経皮・経粘膜吸収製剤の保存方法及び経皮・経粘膜吸収製剤包装体
JP6087839B2 (ja) 2011-12-27 2017-03-01 帝國製薬株式会社 トルテロジン含有貼付剤
US20250177381A1 (en) * 2022-02-22 2025-06-05 Shanghai Yonsun Biotechnology Co., Ltd. Medicinal salt of cariprazine and crystal form thereof, pharmaceutical composition thereof, and preparation method therefor and use thereof
CN117384073A (zh) * 2022-07-11 2024-01-12 南京毓浠医药技术有限公司 一种维a酸醇胺类复合物及其制备方法和应用
CN118121574A (zh) * 2022-12-02 2024-06-04 南京毓浠医药技术有限公司 一种含维a酸组合物及其制备方法和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5382600A (en) 1988-01-22 1995-01-17 Pharmacia Aktiebolag 3,3-diphenylpropylamines and pharmaceutical compositions thereof
SE9203318D0 (sv) 1992-11-06 1992-11-06 Kabi Pharmacia Ab Novel 3,3-diphenylpropylamines, their use and preparation
AU728395B2 (en) * 1996-07-19 2001-01-11 Gunnar Aberg S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders
KR20000057548A (ko) 1996-12-13 2000-09-25 알프레드 엘. 미첼슨 광학적 전송물질 및 결합재
SE9802864D0 (sv) * 1998-08-27 1998-08-27 Pharmacia & Upjohn Ab Transdermally administered tolterodine as antimuscarinic agent for the treatment of overactive bladder
PE20020547A1 (es) 2000-10-24 2002-06-12 Upjohn Co Uso de la tolterodina en tratamientos del asma
US7005449B2 (en) * 2002-04-23 2006-02-28 Pharmacia & Upjohn Company Tolterodine salts

Similar Documents

Publication Publication Date Title
HRP20192202T1 (hr) Acc inhibitori i njihove upotrebe
WO2011012816A3 (fr) Formulation pharmaceutique
ME02558B (me) Inhibitori replikacije virusa gripa
JP2011518833A5 (enExample)
EP2389375A4 (en) Hydroxamic acid derivatives
JP2012107057A5 (enExample)
JP2011168603A5 (enExample)
JP2013507408A5 (enExample)
JP2011510079A5 (enExample)
JP2013532130A5 (enExample)
BRPI1008215A2 (pt) "composição azeotrópica"
WO2012015681A3 (en) Drug-ligand conjugates, synthesis thereof, and intermediates thereto
CL2007003875A1 (es) Compuestos derivados de amidas del acido 3-amino tetrahidrofurano-3-carboxilico; procedimiento de preparacion de dichos compuestos.
EP2666765A3 (en) Process for the preparation of substituted 3-(1-amino-2-methyl-pentane-3-yl)phenyl compounds
JP2011512405A5 (enExample)
HUE040484T2 (hu) Eljárás (3S,3S')4,4'-diszulfándiilbisz(3-aminobután-1-szulfonsav) elõállítására
MX2012007426A (es) Derivados de amino-heteroarilo como bloqueadores de los canales activados por la hiperpolarizacion, controlados por nucleotidos ciclicos.
JP2011522850A5 (enExample)
JP2012501302A5 (enExample)
ITRM20080037A1 (it) Procedimento per la ultrapurificazione di alginati.
WO2011081445A3 (ko) 에틸아미노 벤조산 유도체의 치료 용도
ITMI20080011A1 (it) Procedimento per la preparazione di diacereina
TH102902B (th) สารประกอบ
ES1068172Y (es) "condensador para obtener agua del ambiente"
TH105224B (th) โคมไฟ